22-22489013-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_080764.4(ZNF280B):c.386G>A(p.Ser129Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,613,644 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/16 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_080764.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF280B | NM_080764.4 | c.386G>A | p.Ser129Asn | missense_variant | 4/4 | ENST00000626650.3 | NP_542942.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF280B | ENST00000626650.3 | c.386G>A | p.Ser129Asn | missense_variant | 4/4 | 2 | NM_080764.4 | ENSP00000485750.1 | ||
ZNF280B | ENST00000619852.2 | n.386G>A | non_coding_transcript_exon_variant | 4/5 | 1 | ENSP00000480958.1 | ||||
ZNF280B | ENST00000613655.1 | c.386G>A | p.Ser129Asn | missense_variant | 1/2 | 5 | ENSP00000481008.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151866Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251078Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135700
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461778Hom.: 0 Cov.: 32 AF XY: 0.0000151 AC XY: 11AN XY: 727174
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151866Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74158
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 28, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at